Physician profile
Maninder Deswal
NPI 1811235872
$1,098.56
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $349 · 2021: $377 · 2022: $150 · 2024: $17.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $417.55 | 2020-2022 | |
| Organogenesis INC. | $94.31 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $88.58 | 2021-2022 | |
| Melinta Therapeutics, LLC | $62.13 | 2019-2021 | |
| Wright Medical Technology, INC. | $59.04 | 2019 | |
| Osteomed LLC | $51.23 | 2021-2022 | |
| Bioventus LLC | $51.11 | 2020-2021 | |
| Orthofix Medical, INC. | $33.93 | 2019-2021 | |
| Grt US Holding, INC. | $32.07 | 2021-2022 | |
| Paragon 28, INC. | $29.29 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $28.76 | 2019 | |
| Arthrosurface Incorporated | $23.04 | 2019 | |
| Abbvie INC. | $22.81 | 2022 | |
| Kerecis Limited | $20.30 | 2021 | |
| Boston Scientific Corporation | $17.63 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $15.25 | 2020 | |
| Bsn Medical INC | $14.00 | 2020 | |
| Nabriva Therapeutics, Plc | $13.54 | 2021 | |
| Kci USA, INC. | $12.03 | 2019 | |
| Zimmer Biomet Holdings, INC. | $11.96 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maninder Deswal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.